Unigene Laboratories, Inc. UGNEQ Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Unigene Laboratories, Inc. UGNEQ Company Overview 

Stock Message Board http://investorshangout.com/search?q=UGNEQ&am...mp;yt1=Go!

Unigene Laboratories, Inc. UGNEQ Current Price and Quotes
Last Price 0.0009
Previous Close 0.0009 Open 0.0009
Daily Range 0.0009 - 0.0009 52wk Range 0.32 - 0.0007
Volume 36,550 Dividend N/A
Average Vol (3m) 768,574 Yield N/A
Unigene Laboratories, Inc. UGNEQ
Company Information

81 Fulton Street
Boonton, NJ 07005

Website: http://www.unigene.com
Phone: 973-265-1100
Email: jthomas@unigene.com

Unigene Laboratories, Inc. UGNEQ
Unigene is building a robust portfolio of proprietary partnerships in this expanding drug class based on the Company’s Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scal...



Unigene Laboratories, Inc. UGNEQ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Mar 31, 2013 10-Q
CIK 0000352747
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

William Steinhauer VP, Fin.
Company Directors

Not Available
Company Notes

Note = On July 2, 2013, Unigene Laboratories, Inc. filed a voluntary petition for relief under Chapter 7 of the United States Bankruptcy Code in the United States Bankruptcy Court of the District of New Jersey.
Service Providers

Auditor/Accountant
Grant Thornton LLP
226 Causeway Street
Boston, MA, 02114
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Unigene Laboratories, Inc. UGNEQ
UGNEQ Security Details

Share Structure

Market Value1 $86,381 a/o Sep 12, 2013
Shares Outstanding 95,978,952 a/o Apr 30, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.01
Shareholders

Shareholders of Record 462 a/o Mar 15, 2013
Security Notes

New Issue=8-87 4,999,998 shs in units (3 shs Com & 3 Class A Warr 8-11-92) at $6 per unit by D.H. Blair & Co., Inc.
Short Selling Data

Short Interest 0 (-100%)
Jul 31, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Registrar and Transfer Co.

Unigene Laboratories, Inc. UGNEQ Recent News

Aug 5, 2013 Enteris BioPharma Initiates Business and Development Activities Targeting Oral Delivery of Peptides and Small Molecule Therapeutics


Unigene Laboratories, Inc. UGNEQ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 9,438 20,508 11,340 12,792
Cost of Revenue 1,639 1,552 2,608 2,171
Gross Profit 7,799 18,957 8,732 10,621
Operating Expenses

Research and Development 5,311 9,016 6,428 12,351
Sales, General and Admin. 11,777 13,407 12,628 10,649
Non-Recurring Items - - - -
Other - - - -
Operating Income (9,371) (3,466) (10,324) (12,380)
Income From Continuing Operations

Add'l Income/Expense Items (12,344) 6,253 (14,872) 3,795
Earnings Before Interest and Tax (21,689) 2,787 (25,196) (8,584)
Interest Expense 13,858 10,484 8,039 4,862
Earnings Before Tax (35,547) (7,697) (33,234) (13,447)
Income Tax (1,261) (601) (701) (67)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary (56) - - -
Net Income Cont. Operations (34,343) (7,096) (46,915) (13,380)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (34,286) (7,096) (32,534) (13,380)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (34,286) (7,096) (32,534) (13,380)

UGNEQ Unigene Laboratories, Inc. Research DD Guide

UGNEQ Unigene Laboratories, Inc. Stock Message Board http://investorshangout.com/search?q=UGNEQ&am...mp;yt0=Go!
UGNEQ Unigene Laboratories, Inc. Stock Quote http://www.otcmarkets.com/stock/UGNEQ/quote
UGNEQ Unigene Laboratories, Inc. Stock Chart http://www.otcmarkets.com/stock/UGNEQ/chart
UGNEQ Unigene Laboratories, Inc. Company Info http://www.otcmarkets.com/stock/UGNEQ/company-info
UGNEQ Unigene Laboratories, Inc. Recent News http://www.otcmarkets.com/stock/UGNEQ/news
UGNEQ Unigene Laboratories, Inc. Financials http://www.otcmarkets.com/stock/UGNEQ/financials
UGNEQ Unigene Laboratories, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/UGNEQ/filings
UGNEQ Unigene Laboratories, Inc. Short Sales http://www.otcmarkets.com/stock/UGNEQ/short-sales
UGNEQ Unigene Laboratories, Inc. Insider Disclosure http://www.otcmarkets.com/stock/UGNEQ/insider-transactions
UGNEQ Unigene Laboratories, Inc. Research Reports http://www.otcmarkets.com/stock/UGNEQ/research
UGNEQ Unigene Laboratories, Inc. Summary http://finance.yahoo.com/q?s=UGNEQ
UGNEQ Unigene Laboratories, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=UGNEQ+Historical+Prices
UGNEQ Unigene Laboratories, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=UGNEQ
UGNEQ Unigene Laboratories, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=UGNEQ+Basic+Chart
UGNEQ Unigene Laboratories, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=UGNEQ+Basic+Tech.+Analysis
UGNEQ Unigene Laboratories, Inc. Headlines http://finance.yahoo.com/q/h?s=UGNEQ+Headlines
UGNEQ Unigene Laboratories, Inc. Press Releases http://finance.yahoo.com/q/p?s=UGNEQ+Press+Releases
UGNEQ Unigene Laboratories, Inc. Company Profile http://finance.yahoo.com/q/pr?s=UGNEQ+Profile
UGNEQ Unigene Laboratories, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=UGNEQ+Key+Statistics
UGNEQ Unigene Laboratories, Inc. Industry http://finance.yahoo.com/q/in?s=UGNEQ+Industry
UGNEQ Unigene Laboratories, Inc. Major Holders http://finance.yahoo.com/q/mh?s=UGNEQ+Major+Holders
UGNEQ Unigene Laboratories, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=UGNEQ+Insider+Transactions
UGNEQ Unigene Laboratories, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=UGNEQ+Insider+Roster
UGNEQ Unigene Laboratories, Inc. Income Statement http://finance.yahoo.com/q/is?s=UGNEQ
UGNEQ Unigene Laboratories, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=UGNEQ
UGNEQ Unigene Laboratories, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=UGNEQ+Cash+Flow&annual
UGNEQ Unigene Laboratories, Inc. Nasdaq http://www.nasdaq.com/symbol/UGNEQ
UGNEQ Unigene Laboratories, Inc. Market Watch http://www.marketwatch.com/investing/stock/UGNEQ
UGNEQ Unigene Laboratories, Inc. Bloomberg http://www.bloomberg.com/quote/UGNEQ:US
UGNEQ Unigene Laboratories, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=UGNEQ
UGNEQ Unigene Laboratories, Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=UGNEQ
UGNEQ Unigene Laboratories, Inc. Barchart http://www.barchart.com/quotes/stocks/UGNEQ
UGNEQ Unigene Laboratories, Inc. OTC Short Report http://otcshortreport.com/index.php?index=UGNEQ
UGNEQ Unigene Laboratories, Inc. Investopedia http://www.investopedia.com/markets/stocks/UGNEQ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

A. O. Smith Reports Q3 2026: A Strategic Shift

Updated Category News Views 22

A. O. Smith Navigates Change in Third Quarter 2026 It's been a gritty third quarter for A. O. Smith, as the company maneuvers through domestic challenges and crafts a strategic future with international tweaks. They've hammered out $941 million in sales but found themselves grappling with net earnings dipping to $126 million, or $0.93 per diluted share, a mere blip from...

Continue Reading
Oracle's Bold Vision: Targeting $225B Revenue by 2030

Updated Category News Views 132

Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...

Continue Reading
Banco Macro S.A. Plans $160B Share Buyback Initiative

Updated Category News Views 24

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Continue Reading
Abbe Lane's Estate Auction: Glamour Up for Grabs

Updated Category News Views 72

Glamour from the Mid-Century Comes to the Auction Block In a world obsessed with the flavor of the month, a collection that truly turns heads by sailing in on a wave of genuine mid-century splendor isn't something you stumble upon every day. John Moran Auctioneers has the privilege to crack open the vault on the Estate of Abbe Lane, a name that once rolled off tongues...

Continue Reading
Booming Door Market: $105.93B by 2031, Key Insights

Updated Category News Views 16

Introduction to the Future of the Door Industry Here's what gets me grinning—despite the market doomsayers, there's one industry that's swinging open new opportunities every year: doors. Projected to hit a whopping $105.93 billion by 2031, this market isn't just about hinges and handles. It's a sign of booming construction, urban development, and rising consumer...

Continue Reading
Famous Brands Slashes Fees to Boost Franchise Growth

Updated Category News Views 17

Throwing a Sweet Deal for New Franchise Owners Talk about a move that’s got the industry buzzing—Famous Brands International, the folks behind Mrs. Fields and TCBY, just rolled out a tantalizing offer you don’t see every day. They’re slashing franchise fees and royalties by half for new franchisees who jump onboard before the ball drops on 2026. I’ll tell ya,...

Continue Reading
Fourth PAW Patrol Movie Announced by Spin Master

Updated Category News Views 88

Spin Master and Paramount Roll the Dice Again Ah, Spin Master, you sly devils! Just when we thought they'd caught the last of those daring pups, they're back with another PAW Patrol flick. Yep, a fourth movie is revving up its engines, and this one's coming out of the gates in 2029, thanks to the trio of Spin Master Entertainment, Paramount Animation, and Nickelodeon...

Continue Reading
ZYNLONTA's Japanese Push: ADC Therapeutics Gains Traction

Updated Category News Views 33

ADC Therapeutics Eyes Japan with ZYNLONTA Bet These days, everyone seems to have their eyes on the Far East, and ADC Therapeutics is no exception. They're making a strategic leap by letting their budding blockbuster ZYNLONTA make waves in Japan. With the fresh file submitted for approval, it looks like they're hoping to capture market ground that could pay off big time...

Continue Reading
Oxford Bank Reports Strong Q3 Amid Challenges

Updated Category News Views 0

Digging Into Oxford Bank's Q3 Numbers You ever wonder how a smaller banking outfit yet to become a household name manages to punch above its weight? Let's look at Oxford Bank Corporation's (OTCQX: OXBC) third-quarter antics, where dreams of better margins and loan growth dance, even as operational costs spike. Net Income Climbs Despite Rising Costs The headline here is...

Continue Reading
Bandwidth Welcomes Chip Schroeder: Key Board Makeover

Updated Category News Views 14

Turning the Page at Bandwidth Bandwidth Inc. (NASDAQ:BAND) just shook up its executive roster by bringing in a heavy hitter. Chip Schroeder's landing on the board is a bold move from a strategic player in the cloud communications space. This guy's not your average board member; he's a veteran navigator through stormy market waters, and at Bandwidth, it seems he'll be...

Continue Reading

Top 5 Most Recently Viewed Articles

Aura Minerals Implements Voluntary Delisting from Major Exchange

Updated Category News Views 152

Aura Minerals Plans to Voluntarily Delist from TSX Aura Minerals Inc. (Nasdaq: AUGO) (TSX: ORA) (B3: AURA33) recently announced its intention to apply for a voluntary delisting of its common shares from the Toronto Stock Exchange (TSX). This decision comes after the company's successful listing on Nasdaq, marked on July 16, 2025, and represents a strategic move to align...

Continue Reading
Outbrain Secures $637.5 Million in Senior Secured Notes

Updated Category News Views 129

Outbrain Inc. Successfully Closes New Senior Secured Notes Outbrain Inc. (NASDAQ: OB), now operating under the Teads brand, recently announced a significant development in its financial strategy. The company has successfully completed its Rule 144A/Reg S private offering, raising $637.5 million through the issuance of senior secured notes due in 2030. This transaction,...

Continue Reading
Discover Instant Fashion Shopping with FindGPT from Aesthetic

Updated Category News Views 104

Aesthetic Unveils FindGPT: Revolutionizing Fashion Shopping FindGPT by Aesthetic has officially launched on the App Store, transforming how users can shop for fashionable items found online. This innovative app allows users to turn their fashion inspiration into actionable shopping experiences in just a few taps. Transforming Inspiration into Actionable Shopping Imagine...

Continue Reading
Celebrating Academic Excellence: The Dominguez Firm Scholarships

Updated Category News Views 267

Recognizing the 2025 Scholarship Recipients At The Dominguez Firm, we believe in the power of education and the impact it creates within communities. This spring, we’re proud to honor two outstanding recipients of our scholarship program, Jamie Julien and Eric Lau. Their dedication to academic excellence and commitment to serving their communities truly sets them apart....

Continue Reading
Baxter International Investors Urged to Join Class Action Lawsuit

Updated Category News Views 194

Baxter International Investors Encouraged to Act As challenges continue to mount for Baxter International, Inc. (NYSE: BAX), investors are urged to seek legal assistance regarding a potential class action lawsuit aimed at recovering losses. The lawsuit centers around significant allegations of securities fraud that have affected numerous investors over a defined period....

Continue Reading